WallStSmart
EWTX

Edgewise Therapeutics Inc

NASDAQ: EWTX · HEALTHCARE · BIOTECHNOLOGY

$30.45
-1.74% today

Updated 2026-04-29

Market cap
$3.27B
P/E ratio
P/S ratio
EPS (TTM)
$-1.63
Dividend yield
52W range
$12 – $35
Volume
0.9M

Edgewise Therapeutics Inc (EWTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+2.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-11.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.4%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-6.2%
2025-08-07
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-19$-0.47-7.8%$30.15$29.31-2.8%
2025-11-06$-0.39+2.5%$17.37$17.16-1.2%
2025-08-07$-0.34+19.0%$13.52$12.68-6.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.44$-0.47-7.8%
2025-09-30$-0.40$-0.39+2.5%
2025-06-30$-0.42$-0.34+19.0%
2025-03-31$-0.42$-0.43-2.1%
2024-12-31$-0.42$-0.42+0.5%$2.12M-6.0%
2024-09-30$-0.37$-0.36+2.7%
2024-06-30$-0.34$-0.34+0.0%
2024-03-31$-0.39$-0.33+15.4%
2023-12-31$-0.43$-0.47-9.3%$2.25M
2023-09-30$-0.40$-0.41-2.5%
2023-06-30$-0.40$-0.34+15.0%

Frequently asked questions

Has Edgewise Therapeutics Inc beaten earnings estimates?
Edgewise Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +2.9% over the last 4 quarters.
How does EWTX stock react to earnings?
EWTX stock has moved an average of -3.4% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.